title: The use of sirolimus to treat Kaposi's sarcoma in an HIV-negative rheumatoid arthritis patient on disease-modifying drug therapies.
authors.affiliation: Department of Dermatology, University of California San Diego, San Diego, CA, USA.
authors.forename: Wiggin
authors.initials: W
authors.lastname: Wu
authors.affiliation: Department of Dermatology, University of California San Diego, San Diego, CA, USA.
authors.forename: Chao
authors.initials: C
authors.lastname: Li
authors.affiliation: Department of Dermatology, University of California San Diego, San Diego, CA, USA.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Lee
authors.affiliation: Department of Dermatology, University of California San Diego, San Diego, CA, USA.
authors.forename: Tissa
authors.initials: T
authors.lastname: Hata
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D018023:HIV Seronegativity; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D011241:Prednisone / Q000009:adverse effects; D012514:Sarcoma, Kaposi / Q000139:chemically induced / Q000188:drug therapy*; D020123:Sirolimus / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D000903:Antibiotics, Antineoplastic; D007166:Immunosuppressive Agents; D011241:Prednisone; D020123:Sirolimus; D008727:Methotrexate